Yearly zoledronic acid non-inferior to daily bisphosponates

17 April 2009 | by Nicola Garrett Print this article Comments Share this article
A single annual infusion of zoledronic acid is at least as effective as a daily oral bisphosponates at preventing and treating glucocorticoid- induced osteoporosis, according to the latest findings from the HORIZON study.  ...

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites